Health

Zimmer Biomet India Launches Zimmer Biomet on Wheels Campaign

NEW DELHI, Sept. 6, 2023 /PRNewswire/ -- Zimmer Biomet India today announced the launch of the Zimmer Biomet on Wheels campaign, a mobile vehicle housing the company's innovative products and solutions, including Knee, Hips, Shoulder, and Sports Medicine product portfolios that leverage data, ana...

2023-09-06 11:30 2261

MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

GENEVA, Sept. 6, 2023 /PRNewswire/ -- The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which is where ...

2023-09-06 08:00 1787

Infinitus Showcases Its Health Food Brand Oriherb at the China Quality Conference in Chengdu

GUANGZHOU, China, Sept. 6, 2023 /PRNewswire/ -- Co-hosted by the State Administration for Market Regulation, the People's Government ofSichuan Province and the Chengdu Municipal People's Government, the 5th China Quality Conference took place inChengdu, Sichuan province on September 1-3. Infinitu...

2023-09-06 08:00 1799

iHerb Celebrates 27 Years of Quality and Announces Historic Anniversary Sale

Leading health and wellness eCommerce store celebrates another year of accomplishments fueled by its "quality first" foundation to its products, customers, and employees, offering daily deep discounts for a limited time IRVINE, Calif., Sept. 6, 2023 /PRNewswire/ -- iHerb proudly announces its 27...

2023-09-06 02:55 2226

MALAYSIA HEALTHCARE TRAVEL COUNCIL SELECTS MAYO CLINIC TO PROVIDE STRATEGIC COUNSEL TO FURTHER ADVANCE MEDICAL EXCELLENCE IN MALAYSIA

PUTRAJAYA, Malaysia, Sept. 5, 2023 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), an agency established under the purview of Ministry of Health Malaysia, has officially announced the successful establishment of a Memorandum of Understanding (MoU) with US-basedMayo Clinic

2023-09-05 22:37 2059

SIBIONICS Launches the Breakthrough SIBIO KS1 CKM for Ketone Level Monitoring

SHENZHEN, China, Sept. 5, 2023 /PRNewswire/ -- SIBIONICS, a leader in bio-wearable consumer electronics, is pleased to announce the launch of SIBIO KS1 Continuous Ketone Monitoring (CKM) System, the company's newest biometric wearable device designed to measure ketone levels. Boasting CE certific...

2023-09-05 21:56 2635

LILYSILK Honors International Day of Charity: 1,500 Eye Masks Donated to National Breast Cancer Foundation

NEW YORK, Sept. 5, 2023 /PRNewswire/ -- On the occasion of the International Day of Charity, occurring onSeptember 5, LILYSILK, the world's leading silk brand with a mission to inspire people to live better, sustainable lives, is proud to announce it is continuing its support to National Breast C...

2023-09-05 21:30 1468

Exosomes functionally deliver siRNAs in vivo to repress tumor growth

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- VesiCURE Therapeutics Co. Ltd., a biotechnology company located in Suzhou,China, recently released a preprint on BioRxiv titled "Harnessing extracellular vesicles for efficient siRNA delivery in vitro and in vivo" (doi:https://doi.org/10.1101/2023.0...

2023-09-05 21:20 1700

Neurophet, the first company in Korea, selected by Roche Diagnostics for Startup Creasphere's APAC innovation program

- Aim to evaluate and explore the commercialization opportunities of an amyloid-positive prediction technology for Alzheimer's disease based on MRI analysis SEOUL, South Korea, Sept. 5, 2023 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced ...

2023-09-05 21:00 1786

YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference

GAITHERSBURG, Md., Sept. 5, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious di...

2023-09-05 20:30 1584

I-Mab Announces Upcoming Participation at September Conferences

ROCKVILLE, Md. and SHANGHAI, Sept. 5, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies an...

2023-09-05 20:00 1365

David Topper Joined Inmagene as CFO

SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced the appointment ofDavid Topper as Chief Financial Officer (C...

2023-09-05 20:00 1544

Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile

Alteogen expects Tergase® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages.  Compared with other commercially available hyaluronidase products, Tergase® showed no incidence of anti-drug antibodies (ADA).  The occurrence of ADA is known ...

2023-09-05 20:00 1250

Baird Medical's Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China

GUANGZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., h...

2023-09-05 17:00 1247

"AIA Creator Fund" to Provide a Total of HK$5 Million in Support of Youth-driven Social Innovation Projects

HONG KONG, Sept. 5, 2023 /PRNewswire/ -- AIA Hong Kong has announced the launch of the "AIA Creator Fund", an initiative that will provide a total ofHK$5 million in funding as well as guidance and support for young people to carry out social innovation projects for the betterment of the community...

2023-09-05 16:29 2161

CIGNA HEALTHCARE LAUNCHES NEW GLOBAL HEALTH BENEFITS PLAN FOR ADULTS AGED 60+

* Bespoke solution designed to meet growing consumer demand for international health coverage * Includes full cancer coverage and benefits to support health and well-being across all areas of life * Includes optional outpatient cover for certain chronic conditions, including type 2 diabetes...

2023-09-05 15:00 1737

Discover the Legumes From Europe project. Which legumes have the highest amounts of protein and why you should make them part of your diet.

SYDNEY, Sept. 5, 2023 /PRNewswire/ -- Encouraging the consumption of legumes is one of the objectives of theLegumes from Europe campaign led by ANICAV – the National Association of Canned Vegetable Industries – and co-funded by the European Union to promote a healthier and more active lifestyle, ...

2023-09-05 15:00 1490

European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies

HEIDELBERG, Germany, Sept. 5, 2023 /PRNewswire/ -- A ground-breaking research collaboration between European Wellness Biomedical Group (EWBG), through its subsidiaries European Wellness Academy (EWA) and Baden R&D Laboratories (Baden), and Heidelberg's Institute of Anatomy and Cell Biology has yi...

2023-09-05 14:06 2167

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1484

ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001

*  Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform *  ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data *  ACM is in partnering d...

2023-09-05 14:00 1637
1 ... 170171172173174175176 ... 847